$ARMK

Aramark beats fiscal Q3 estimates as revenue growth accelerates

Aramark (NYSE:ARMK) reported fiscal Q3 2026 adjusted EPS of $0.52, above the $0.48 consensus. Revenue rose 9% to $5.1 billion versus $4.92B expected. The company cited 9% organic growth, record ~98% client retention, and $1.6B new client wins. It raised FY2026 organic revenue growth to 9% to 10%.

Original reporting
Published Aug 13, 2026, 12:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aramark beats fiscal Q3 estimates as revenue growth accelerates — source image
Decision brief

The 30-second read

$ARMKBullishMed
01

Why it matters

The key tradable update is the raised FY2026 organic revenue growth range to 9% to 10% from 7% to 9%, alongside maintained adjusted operating income and EPS growth guidance. This combination typically drives estimate revisions and can affect valuation multiples if investors believe the growth is durable.

02

Market read

A Q3 beat with a raised FY2026 organic revenue outlook is a direct catalyst for earnings model updates, even though the immediate pre-market price reaction was minimal.

03

What to watch

The article notes a fiscal calendar shift affecting reported growth (Education) and highlights constant-currency measures; traders may discount reported growth quality and watch for FX and margin normalization.

Relevance 8/10Novelty 8/10Timing: pre-market today after fiscal Q3 results and FY2026 outlook raise

Background

Aramark’s fiscal Q3 performance is framed around organic growth, new client wins, and record client retention, with a raised FY2026 organic revenue outlook.

Company-level read

Ticker impact

$ARMKBullishMedium confidence
Context

Aramark reported fiscal Q3 adjusted EPS of $0.52 and revenue of $5.1B, beating estimates, and raised FY2026 organic revenue growth to 9% to 10%.

Expected impact

Likely supportive for the stock on follow-through, though pre-market reaction was muted (-0.18%), implying investors may already be positioned for the beat.

Evidence & confidence

The article provides concrete Q3 results and a specific FY2026 organic revenue forecast increase, which are direct drivers for earnings revisions. However, the immediate pre-market move being small reduces certainty on incremental upside.

Market effects

Improving organic growth and retention in food and support services can support sentiment toward contract-based facility services peers.

Broad-based U.S. and international growth (including Spain, Canada, U.K., Germany) reduces reliance on a single geography, supporting a more durable demand narrative.

If sustained, the raised revenue growth outlook may reinforce expectations for steady contract catering and facilities spending in developed markets.

Counterpoint

The pre-market reaction was slightly negative despite the beat, suggesting the market may focus on margin sustainability or already priced-in contract win momentum.

Key entities

  • Aramark

    Reported fiscal Q3 adjusted EPS and revenue beats, record client retention, and raised FY2026 organic revenue growth guidance.

  • John Zillmer

    CEO quoted on continued momentum across the portfolio and expansion of Aramark Nexus.

Related articles

$ARMKMedAI 8/10

Why Aramark (ARMK) Stock Is Up Today

Aramark (NYSE:ARMK) shares rose about 9.8% after the company reported better-than-expected Q3 2026 results. Revenue was $5.06B, up 9.3% year over year, and adjusted EPS was $0.52 above consensus. Free cash flow turned positive at $8.69M versus a $33.55M loss a year earlier.

$ARMKMed

Aramark Q3 2026 Earnings Call Summary

Aramark reported Q3 2026 organic revenue up 9% to $5B and record client retention near 98%. New client wins exceeded $1.6B YTD. It raised FY2026 organic growth guidance to 9% to 10% and expects Aramark Nexus to add $400M to $500M annualized revenue. Nexus initial hyperscaler sites are ~$140M and ~$160M per year.

$ARMKMed

Jim Cramer’s Surprise AI Pick: Aramark (ARMK)

Jim Cramer highlighted Aramark (NYSE:ARMK) on CNBC’s Mad Money (Aug. 11), citing AI data center related hospitality work as a catalyst. Aramark reported fiscal Q3 2026 non-GAAP EPS of $0.52 (+$0.04 vs. consensus) and revenue of $5.06B (+9.3% YoY). Management raised full-year organic growth to 9% to 10%.

$ARMKMed

Aramark: New Client Wins Top $1.6 Billion As Retention Reaches Record 98%

Aramark reported more than $1.6B in new client wins in the first three quarters of fiscal 2026, up 51% year over year, with client retention near a record 98%. Q3 revenue rose to about $5.06B from $4.63B, with operating income up 18% to $216M. The company raised its organic revenue outlook to 9% to 10% and targets adjusted EPS growth of 20% to 25%.

$ARMKMed

World Cup, NBA, NHL per-caps drive Aramark earnings gains

Aramark reported Q3 revenue of $5.1B, including $3.5B from its U.S. segment. Total revenue rose 9% YoY, with international up 13% and U.S. up 8%, helped by higher per-cap spending and attendance tied to FIFA World Cup and NBA/NHL playoffs. Through nine months of FY26, Sports, Leisure and Corrections revenue was $3.13B vs $2.87B in FY25.

$ARMKMed

ARMK Q2 Deep Dive: Nexus Expansion and Core Business Growth Drive Momentum

Aramark (NYSE:ARMK) reported Q2 CY2026 revenue of $5.06 billion, up 9.3% year on year and ahead of Wall Street expectations, with non-GAAP EPS of $0.52, 7.2% above consensus. Management attributed growth to record client retention (~98%), new business wins, and expansion of its Aramark Nexus platform. It expects Nexus to add $400–$500 million annual revenue over two years.